Access to Health

Animal Health

Contributing to
Public Health

Contributing to
Public Health
Animal Health

We provide a range of vaccines and treatments to keep livestock healthy to help ensure a stable food supply and help control organisms that can ultimately affect the health of people.

Global trade, global migration and climate change are increasing the spread of highly infectious diseases, such as foot-and-mouth disease, swine fever and peste des petits ruminants, and zoonotic diseases—such as avian flu. Highly infectious diseases have a direct impact on food production and the livelihood of farming families, whose income is dependent on the productivity and survival of their animals. A fast, flexible approach to vaccination can help control such diseases in the animal reservoir, reduce the likelihood of spread to humans and minimize the medical, social and economic impact that could occur if left unchecked.

Salmonella

Food-borne microbial bacteria, such as salmonella, are also a growing concern, particularly for poultry farmers. Human consumption of poultry or eggs infected with the bacteria can result in severe illness, pushing governments and industry to implement adequate measures to reduce this risk. We have developed a Food Safety Platform for poultry farmers that includes several salmonella vaccines and services that ensure effective, timely intervention if an outbreak occurs among poultry. Through the unique Convenience Program Evaluation, our Animal Health business helps poultry producers to identify critical food-safety hazard points and to be prepared to respond quickly and effectively. This combination of vaccines, biosecurity and other measures has contributed significantly to the reduction in incidence of human salmonellosis.

Leishmaniasis

Our Animal Health canine preventive product protects dogs against sandfly-borne leishmaniasis, helping to control one of the world’s deadliest parasitic diseases in the animal reservoir, linked to 60,000 human deaths annually.

Our products help to minimize the annual deaths from animal diseases: 60,000 from leishmaniasis, and 55,000 from rabies.

Rabies

Rabies, a fatal neurological disease, is widespread throughout Africa, with more than 25,000 people—mostly children—dying from the disease each year after being bitten by a domestic dog, the main carrier of the disease. Globally, the disease kills an estimated 55,000 people annually.

Rabies, a fatal neurological disease, is widespread throughout Africa, with more than 25,000 people—mostly children—dying from the disease each year after being bitten by domestic dogs, the main carriers of the disease. Globally, the disease kills an estimated 55,000 people annually.

Our Animal Health business has a history in rabies control. As dogs are the source of the vast majority of human rabies deaths (accounting for up to 99 percent of all rabies transmissions to humans), rabies elimination is feasible by vaccinating dogs.

In 1997, our Animal Health business began supporting the Afya Serengeti Initiative in the Serengeti region of Tanzania by donating canine rabies vaccines. We also provided tools such as all-terrain vehicles and tents to help make sure the project was able to reach the most remote corners of the region. In 2011, the project was extended to the Kenyan villages bordering the Serengeti National Park, resulting in an unbroken vaccination circle around the Serengeti Park. Rabies in humans and domestic animals has now been virtually eliminated from this area, and we have also seen resurgence in the African wild dog population in the Serengeti. This species is categorized as endangered, and as a direct result of the efforts to manage disease the population of these animals is on the rise.

The success of the Afya Serengeti Project inspired us in 2013 to extend our support to the newly founded Mission Rabies project. Mission Rabies focuses on addressing the need for vaccination and education in rabies hotspots in Asia and Africa. The first vaccination campaign took place in targeted locations in India, followed by expansion of the initiative to other parts of India, and to areas of Africa including Malawi. The geography covered by Mission Rabies continues to grow annually, as does the number of doses that we donate to both the Afya Serengeti Initiative and to Mission Rabies. We are proud of our involvement in these initiatives and in their role toward the global goal of eradicating rabies by 2030.